This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Abe M. Macher, MD
Health Resources and Services Administration Rockville, Md

Eric P. Goosby, MD
Office of HIV/AIDS Policy Washington, DC

JAMA. 1997;278(15):1234-1235.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—In their 1991 report, HIV Disease in Correc-tional Facilities, the Presidential National Commission on AIDS recommends that "care and treatment available to HIV-infected inmates in correctional facilities should be equal to that available to HIV-infected individuals in the general community.^" Dr Carpenter and colleagues² and Dr Quinn³ recommend treatment of acute primary HIV infections with combination antiretroviral regimens that include 2 nucleoside reverse transcriptase inhibitors and a protease inhibitor.

Incarcerated populations have higher prevalence rates of HIV infection than the general nonincarcerated population. As unprotected sexual intercourse and sharing of syringes and needles for injection continue to occur within correctional facilities, new cases of HIV infection among inmates most certainly will take place. A considerable number of these newly infected inmates will present with symptomatic primary HIV infections, also referred to as the acute retroviral syndrome. Therefore we believe that primary care clinicians in correctional facilities have . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?